Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for Bipolar Depression
NCT02351869Phase 2Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Aug 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitrous oxide in bipolar disorder (BD) (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Montgomery-Asberg Depression Rating Scale at Day 7. Started Aug 2015; status: terminated.
02
Drugs
nitrous oxide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02351869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351869.